The 19 analysts offering 12-month price forecasts for Teva Pharmaceutical Industries Ltd have a median target of 12.00, with a high estimate of 16.00 and a low estimate of 7.00. The median estimate represents a +42.69% increase from the last price of 8.41.
The current consensus among 23 polled investment analysts is to Hold stock in Teva Pharmaceutical Industries Ltd. This rating has held steady since March, when it was unchanged from a Hold rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share $0.58
Reporting Date Apr 30
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.